Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: SARS-CoV-2 variants supplement stream 1

Université Laval

$50,000.00

COVID-19 Variant Supplement - Development of a portable point-of-care device for rapid testing of SARS-CoV-2

FY 2020-21

Summary
The novel coronavirus (SARS-CoV-2) outbreak that started in December 2019 triggered unprecedented measures to avoid a global pandemic. However, China has been particularly hit with over 70 000 confirmed cases, of which about 80% are in Hubei province. Wuhan, capital city of Hubei, is considered ground zero of the outbreak. Testing is typically performed at centralized facilities with highly qualified personnel operating specialized equipment, RT-qPCR being the current method of choice and DNA sequencing a second choice. The response time between sampling patients and obtaining clinically relevant information usually depends on sample shipping time and clinical lab capacity. In this current outbreak containment situation in China, large portions of the population are quarantined, travel is restricted, and clinical labs are operating well over capacity. We propose to develop a rapid point-of-care test to help mitigate the outbreak of COVID-19. The RNA-based test will be performed with a high sensitivity, label-free sensing method. RNA purification and amplification will not be required. The instrumentation needed will be portable and lightweight to enable frontline workers to rapidly test for SARS-CoV-2. The assay will be developed with an easy-to-use platform that can be operated by untrained personnel. It can thereby be deployed locally, within regions of quarantine at a temporary health centers and neighbourhood clinics, reducing flow of people in urban centers; it can be shipped and used in remote or isolated areas including cruise ships
Program
Operating Grant: SARS-CoV-2 variants supplement stream 1
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
443172
Name
Boudreau Denis
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
COVID-19 Variant Supplement - Development of a portable point-of-care device for rapid testing of SARS-CoV-2
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Operating Grant: SARS-CoV-2 variants supplement stream 1
Keyworddelim
Biomedical Research
Abstract
The novel coronavirus (SARS-CoV-2) outbreak that started in December 2019 triggered unprecedented measures to avoid a global pandemic. However, China has been particularly hit with over 70 000 confirmed cases, of which about 80% are in Hubei province. Wuhan, capital city of Hubei, is considered ground zero of the outbreak. Testing is typically performed at centralized facilities with highly qualified personnel operating specialized equipment, RT-qPCR being the current method of choice and DNA sequencing a second choice. The response time between sampling patients and obtaining clinically relevant information usually depends on sample shipping time and clinical lab capacity. In this current outbreak containment situation in China, large portions of the population are quarantined, travel is restricted, and clinical labs are operating well over capacity. We propose to develop a rapid point-of-care test to help mitigate the outbreak of COVID-19. The RNA-based test will be performed with a high sensitivity, label-free sensing method. RNA purification and amplification will not be required. The instrumentation needed will be portable and lightweight to enable frontline workers to rapidly test for SARS-CoV-2. The assay will be developed with an easy-to-use platform that can be operated by untrained personnel. It can thereby be deployed locally, within regions of quarantine at a temporary health centers and neighbourhood clinics, reducing flow of people in urban centers; it can be shipped and used in remote or isolated areas including cruise ships
Competitiondate
202102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boudreau, Denis
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~